connective tissue disease Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (11)

Phase 2 (4)
Unknown (7)

Interventional (5)
Observational (5)
INTERVENTIONAL (1)

Genzyme, a Sanofi Company (2)
Sanofi (2)
Assistance Publique - Hôpitaux de Paris (1)
Children's Hospital Medical Center, Cincinnati (1)
National Resource Center for Rehabilitation in Rheumatology (1)
Spaarne Gasthuis (1)
University Hospital, Bordeaux (1)
Yale University (1)
dr. Laura C. G. de Graaff-Herder (1)

No (9)
Yes (2)

No (11)

Adult (18+) (11)
Pediatric (Under 18) (1)

I am/have/had

I am/have/hadrheumatism

I am/have/hadscleroderma

I am/have/hadmixed connective tissue disease

I am/have/hadrheumatic diseases

I am/have/hadrheumatoid arthritis

I am/have/hadantiphospholipid syndrome

I am/have/hadgenetic testing

I am/have/hadchest x-ray

I am/have/hadmyositis

I am/have/haddermatomyositis

I am/have/hadsclerosis skin

I am/have/hadpolymyalgia rheumatica

I am/have/hadconnective tissue disease

I am/have/hadpsoriatic arthritis

I am/have/hadpolymyositis

I am/have/hadadult onset still's disease

I am/have/hadarteritis

I am/have/hadraynaud's syndrome

I am/have/hadchest ct

I am/have/hadcongenital disorder

added new label for I am/have/had

more

I am looking for

I am looking forcorticosteroids

I am looking forcyclophosphamide

I am looking forpediatric

I am looking forimmunosuppressive agents

added new label for I am looking for

more

Advanced Filters

Loading...

Found 11 clinical trials

For Seniors
For adults
Recruiting in 10s
Observational Study
all
Dermatology
Recruiting

MPA AUC Monitoring in Patients Receiving MMF for Diffuse Cutaneous or Pulmonary Involvement in Systemic Sclerosis

To define a target value of AUC MPA to improve the modified Rodnan score and / or respiratory impairment (DLCO or FVC) at one year in patients receiving MMF for the treatment of diffuse cutaneous or interstitial lung damage of systemic sclerosis.

cyclophosphamide

sclerosis skin

raynaud disease

pulmonary involvement

raynaud's phenomenon

0 views
16 Feb, 2024
1 location

1
2

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.